Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro

  title={Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
  author={Robert P. Lisak and Joyce A Benjamins and Liljana Nedelkoska and Jennifer L Barger and Samia Ragheb and Boli Fan and Nadia Ouamara and Trina A. Johnson and Sathyanath Rajasekharan and Amit Bar-Or},
  journal={Journal of Neuroimmunology},

Figures from this paper

B cells in Multiple Sclerosis: Good or bad guys?
The BAFF-APRIL system, which promotes B-cell activation and survival, seems to play a decisive role in a way that is so far incompletely understood: A recombinant soluble receptor, atacicept, which blocks both BAFF and APRIL, unexpectedly exacerbates MS.
Therapies for multiple sclerosis targeting B cells
  • R. Milo
  • Biology
    Croatian medical journal
  • 2019
Ocrelizumab is the first disease-modifying drug that has shown efficacy in primary-progressive MS, and is currently approved for both indications and another promising approach is the inhibition of Bruton's tyrosine kinase, a key enzyme that mediates B cell activation and survival, by agents such as evobrutinib.
B cells in MS and NMO: pathogenesis and therapy
Evidence for B cell and Ig contribution to human MS and NMO pathogenesis, pro-inflammatory and regulatory B cell effector functions, impaired B cell immune tolerance, the B cell-fostering microenvironment in the CNS, and B Cell-targeted therapeutic interventions for MS andNMO are discussed.
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders
This review will describe and summarize pro-inflammatory B cell properties in these three CNS demyelinating disorders, and provide an overview on the emerging concept that B cells or B cell subsets may exert immunologically counterbalancing properties, which may be therapeutically desirable to maintain and foster in inflammatory CNS demYelination.
Role of B cells and antibodies in multiple sclerosis.
Molecular targeted therapy against B cells in multiple sclerosis
The successful targeting of B cells with anti‐CD20 monoclonal antibodies without affecting immunoglobulin levels suggests that B cells have antibody‐independent functions in immune regulation in MS.
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
The roles of B cells in multiple sclerosis are discussed and the insights gained from the immunological effects of B cell-targeted therapies and autologous haematopoietic stem cell transplantation are considered, as well as the potential for these insights to improve the authors' understanding.
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
Activated astrocytes in the inflamed MS CNS not only promote a B cell fostering environment, but also actively support the ability of B cells to contribute to the propagation of CNS-compartmentalized inflammation, now thought to play key roles in progressive disease.


Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
It is demonstrated that the number of circulating CD80(+) lymphocytes is increased significantly during MS exacerbations, but is normal in stable MS, and reduction of CD80-mediated costimulation may be one therapeutic mechanism by which IFN-beta acts in MS.
B cells and multiple sclerosis
B cell activation in multiple sclerosis
Results with cultures of unstimulated cell suspensions from MS patients suggested that CSF cells from these patients may be activated in vivo, and the microtechnique should prove useful in functional studies when limited numbers of cells are available.
Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis
Lymphoid follicle‐like structures containing B‐cells, T‐cells and plasma cells, and a network of follicular dendritic cells producing CXCL13 were observed in the cerebral meninges of 2 out of 3 patients with secondary progressive MS, but not in relapsing remitting and primary progressive MS.
Analysis of B‐cell activation of cerebrospinal fluid lymphocytes in multiple sclerosis
Results suggest that CSF cells may be a particularly reactive population compared with PBM.
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
Astrocytes is identified as a nonimmune source of B cell–activating factor of the tumor necrosis factor family and CNS-produced BAFF may support B cell survival in inflammatory diseases and primary B cell lymphoma.
Determinants of Human B Cell Migration Across Brain Endothelial Cells1
It is found that B cells migrated across HBECs more efficiently than T cells from the same individuals and how therapies currently developed to target T cell migration, such as anti-VLA-4 Abs, may impact on B cell trafficking is predicted.
Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis
This study confirms that effector cytokine production by normal human B cells is context dependent and demonstrates that this involves the reciprocal regulation of proinflammatory and anti-inflammatory cytokines, and proposes a model that ascribes distinct and proactive roles to memory and naive B cell subsets in the regulation of memory immune responses and in autoimmunity.